A 43-year-old man presented with a chief complaint of a sudden onset “gray spot” associated with a decrease in central vision in the left eye 2 days earlier.
The patient had no ocular history. His medical history was significant for hypertensive emergency and non-ST-elevation myocardial infarction (NSTEMI) in the setting of COVID infection 4 months prior, after which he was started on several antihypertensive medications and a statin.
On exam, best uncorrected distance visual acuity was 20/25 in the right eye and counting fingers at 6 feet in the left eye. Pupils were equal, round